|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 03, 2024 ) As per Maximize Market research, Tunisia Pharmaceutical Market size was valued at US$ 1.69 Bn in 2021 and the total revenue is expected to grow at 12.9 % through 2022 to 2029, reaching nearly US$ 4.47 Bn.
Tunisia, the smallest nation in North Africa has well developed pharmaceutical sector, with 49% of generic drugs produced locally and 51% being imported. Tunis the capital hosts around 39 pharmaceutical companies. Established facilities for R&D, a larger consumer base, growing disposable income are some of the driving factors.
Request Sample Copy of this Report : https://www.maximizemarketresearch.com/request-sample/119566/
The pharmaceutical export is in Europe and west Africa. As of August 2021, USD 105 million were invested in Tunisia. SAIPH (Société Arabe des Industries Pharmaceutiques) is one of the favourable investments for increasing export. Joint ventures with multinational companies and subsequent investments has been catalyst to R&D facilities fostering research clusters.
Pfizer is the leading drug company in Tunisia followed by Sanofi-Aventis Tunisia and Adwa.
Request Sample Copy of this Report : https://www.maximizemarketresearch.com/request-sample/119566/
Tunisia Pharmaceutical Market Segmentation
by Formulation
Tablets
Capsules
Injectables
BFS-mode
Non-BFS-mode
Sprays
BFS-mode
Non-BFS-mode
Suspensions
BFS-mode
Non-BFS-mode
Powders
Other Formulations
BFS-mode
Non-BFS-mode
Request Sample Copy of this Report : https://www.maximizemarketresearch.com/request-sample/119566/
Tunisia Pharmaceutical Key Players:
Adwya
Sanofi (Sanofi-Aventis Tunisia)
Teriak
Opalia pharma
Les Laboratoires UNIMED
Maximize Market Research is leading Healthcare research firm, has also published the following reports:
UK over Counter Pharmaceuticals Market size was valued at USD 3780 Million in 2023 and the total UK over Counter Pharmaceuticals revenue is expected to grow at a CAGR of 3.43% from 2023 to 2030, reaching nearly USD 4788 Million in 2030.
China Over Counter Pharmaceuticals Market size was valued at USD 32.20 Billion in 2023 and the total China Over-The-Count (OTC) Pharmaceutical Market revenue is expected to grow at a CAGR of 7.02 % from 2023 to 2030, reaching nearly USD 51.77 Billion.
About Maximize Market Research
Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities and technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics and communications, Internet of Things, Food and Beverages, Aerospace and defense, and other manufacturing sectors.
MAXIMIZE MARKET RESEARCH PVT. LTD.
L Godage
09607365656
akash.r@maximizemarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
